Lina van der Straten

Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019

Lina van der Straten, Mark‐David Levin, Manette A. W. Dinnessen et al. · Blood Cancer Journal · 2023 · 37 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL

Lina van der Straten, Claudia A.M. Stege, Sabina Kersting et al. · Blood · 2023 · 28 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +6

Detecting measurable residual disease beyond 10−4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL

Paul J. Hengeveld, Michèle Y. van der Klift, P. Martijn Kolijn et al. · Blood · 2022 · 24 citations · Full text

Medicine, Bioinformatics, Molecular Medicine +14

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

Arnon P. Kater, Marinus H. J. van Oers, Yvette van Norden et al. · Haematologica · 2018 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9